Global Renal Insufficiency Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Renal Insufficiency Industry Expected To Reach By 2029, Starting From 2025 Levels?

The renal insufficiency market has seen swift expansion in recent years. Its size is expected to increase from $10.87 billion in 2024 to $12.1 billion in 2025, progressing at a compound annual growth rate (CAGR) of 11.4%. The contributing factors to this growth historically include a rise in high blood pressure and diabetes cases, the increasing prevalence of chronic kidney disease (CKD), a growing incidence of urinary tract obstructions, an aging population, and enhanced awareness and education regarding kidney health.

The renal insufficiency market size is projected to experience substantial growth over the coming years, with expectations to reach $18.52 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.2%. This projected expansion during the forecast period is primarily driven by the increasing incidence of acute kidney injuries (AKI), the growing acceptance of home-based treatment options, a significant rise in healthcare expenditure, and increased investments in research and development. Key trends anticipated in this period include advancements in medical technology, improvements in technology and treatment options, the integration of personalized medicine approaches, further advancements in dialysis technology, and the creation of novel and innovative medications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

What Are The Drivers Pushing New Developments In The Renal Insufficiency Market?

The rising incidence of high blood pressure and diabetes cases is projected to fuel the expansion of the renal insufficiency market in the coming years. These conditions are linked to factors such as poor dietary habits, insufficient physical activity, obesity, genetic predispositions, and an aging population. Elevated blood pressure harms kidney blood vessels through scarring and diminished filtration, while diabetes causes kidney vessels to thicken and become overworked due to high blood sugar levels. Both conditions consequently hasten kidney deterioration, culminating in renal insufficiency. As an illustration, in May 2024, the National Health Service, a UK government body, reported that in December 2023, high blood pressure diagnoses in the South East rose by 71,120 patients, signifying a 5.4% increase from December 2022. Moreover, in April 2023, according to the British Diabetic Association, a UK-based charity, 4.3 million individuals in the UK are living with a diabetes diagnosis. Consequently, the growing number of high blood pressure and diabetes diagnoses is powering the growth of the renal insufficiency market.

What Are The Major Segments Identified In The Renal Insufficiency Market?

The renal insufficiencymarket covered in this report is segmented –

1) By Treatment Type: Medications; Dialysis; Kidney Transplantation; Other Treatment Types

2) By Disease Stage: Chronic Kidney Disease (CKD) Stages; End-Stage Renal Disease (ESRD)

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End-User: Dialysis Centers; Hospital And Clinics; Research And Academic Institutes

Subsegments:

1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Diuretics; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Sodium Bicarbonate

2) By Dialysis: Hemodialysis; Peritoneal Dialysis; Home Dialysis; Continuous Renal Replacement Therapy (CRRT)

3) By Kidney Transplantation: Living Donor Kidney Transplant; Deceased Donor Kidney Transplant; Kidney Transplant Immunosuppressive Therapy

4) By Other Treatment Types: Lifestyle And Dietary Modifications; Stem Cell Therapy; Gene Therapy

Which Trends Are Impacting The Renal Insufficiency Market?

Leading firms within the renal insufficiency market are creating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) aimed at managing renal and cardiovascular issues in individuals suffering from diabetes and chronic kidney disease (CKD). These GLP-1 RAs work by enhancing glucose regulation, decreasing inflammation, and mitigating oxidative stress in the kidneys, which in turn decelerates the advancement of renal insufficiency. For instance, in January 2025, Novo Nordisk, a Denmark-based pharmaceutical company, secured Food and Drug Administration (FDA) approval for its medication Ozempic (semaglutide). This approval specifically targets the reduction of worsening kidney disease, kidney failure, and cardiovascular death risks in adults diagnosed with type 2 diabetes and chronic kidney disease (CKD). This significant approval underscores the increasing focus on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a comprehensive strategy for simultaneously treating diabetes and renal insufficiency, thereby fulfilling crucial unmet needs for patients experiencing progressive CKD.

Which Major Firms Are Strengthening Their Position In The Renal Insufficiency Industry?

Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, Sorin Group.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

What Are The Regional Market Dynamics Impacting The Renal Insufficiency Industry?

North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Renal Insufficiency Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp

Browse Through More Reports Similar to the Global Renal Insufficiency Market 2025, By The Business Research Company

End Stage Renal Disease Esrd Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/end-stage-renal-disease-esrd-drug-global-market-report

Hepatorenal Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatorenal-syndrome-treatment-global-market-report

Renal Denervation Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795